Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
September 03, 2024 16:50 ET
|
Rapid Micro Biosystems, Inc.
LEXINGTON, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Evome Medical Technologies Reports Second Quarter 2024 Financial Results
August 12, 2024 07:30 ET
|
Evome Medical Technologies Inc.
Stabilizes business with a return to positive Adjusted EBITDAPromotes Gordon Bean to Chief Financial OfficerAnnounces August 19th conference call to discuss financial results SHIRLEY, N.Y., Aug. ...
Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results
August 02, 2024 07:00 ET
|
Rapid Micro Biosystems, Inc.
Record second quarter 2024 revenue of $6.6 million, representing growth of 32% compared to the second quarter of 2023150th Growth Direct® system placed with an existing top 15 global pharma customer...
Rapid Micro Biosystems to Announce Second Quarter 2024 Financial Results on August 2, 2024
July 17, 2024 16:30 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation...
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results
May 03, 2024 07:00 ET
|
Rapid Micro Biosystems, Inc.
Reports first quarter 2024 total revenue of $5.6 million, representing growth of 11% compared to first quarter 2023 Reaffirms full year 2024 total revenue guidance of at least $27.0 million,...
Rapid Microbiology Testing Market is Expected to Reach $8.3 billion | MarketsandMarkets™
April 19, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, April 19, 2024 (GLOBE NEWSWIRE) -- Rapid Microbiology Testing market in terms of revenue was estimated to be worth $5.2 billion in 2024 and is poised to reach $8.3 billion by 2029, growing...
Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024
April 18, 2024 16:30 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation...
Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 - 27, 2024
March 19, 2024 16:30 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
March 12, 2024 16:50 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 06, 2024 18:40 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...